Cas:27187-06-0 4-Bromo-1-hydrazinoisoquinoline manufacturer & supplier

We serve Chemical Name:4-Bromo-1-hydrazinoisoquinoline CAS:27187-06-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Bromo-1-hydrazinoisoquinoline

Chemical Name:4-Bromo-1-hydrazinoisoquinoline
CAS.NO:27187-06-0
Synonyms:4-Brom-1-hydrazino-isochinolin;1H-Pyrazol-1-amine,4-bromo-N,N,5-trimethyl-3-phenyl;4-Brom-1-dimethylamino-5-methyl-3-phenylpyrazol;4-Bromo-1-hydrazinylisoquinoline;4-bromo-1-hydrazino-isoquinoline
Molecular Formula:C9H8BrN3
Molecular Weight:238.08400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:50.94000
Exact Mass:236.99000
LogP:3.05620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Brom-1-hydrazino-isochinolin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-1-hydrazino-isoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Brom-1-dimethylamino-5-methyl-3-phenylpyrazol Use and application,4-Brom-1-hydrazino-isochinolin technical grade,usp/ep/jp grade.


Related News: In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. N-(4-(3-(4-(4-chlorophenyl)-3,6-dihydropyridin-1(2H)-yl)propoxy)phenyl)acetamide manufacturers An inherent advantage of using enzymes for synthetic chemistry is that they increase regio-, enantio-, and stereoselectivity for more efficient conversion of substrate to product. 2-(3-Iodo-benzoylamino)-benzoic acid butyl ester suppliers One of the engineered IgM antibodies, IGM-6268, demonstrated a significantly increased potency against the original SARS-CoV-2 and emerging variants such as the current U.K., South African, and Brazilian variants of concern (VOC) and variants of interest (VOI) nitroso-[1,2,4]thiadiazol-5-yl-amine vendor & factory.